Fortrea Holdings Inc. (FTRE)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Fortrea Holdings Inc. currently loses $2.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 56 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Fortrea Holdings Inc.
Fortrea Holdings Inc. provides contract research and related support to pharmaceutical companies, biotechnology clients, and medical device makers, helping them run clinical studies and related programs globally. The company, which trades on the NASDAQ as FTRE, generated $2.7 billion of revenue in FY2025.
Today's Snapshot
Yesterday FTRE fell 1.6% to 16.79. Fortrea reinstated Jason Knoblauch as chief financial officer.
Trading Volume
Above 10d avg 1.1M
1.2M
vs S&P 500 Today
Underperforming Market
-1.10%
Updated: September 10, 2026 at 12:30 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$14.88 - $18.06Sell
- RSI (14)39.26Neutral
- Stochastic %K (14, 3, 3)8.83Buy
- MACD Level (12, 26)-0.20Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.